Therefore, in metastatic NSCLC, patients with neurologic deterioration and potentially unstable spine should be considered for surgery combined with radiotherapy, especially in patients with mutations of EGFR or ALK expected to have a longer life expectancy despite a lower Tokuhashi score. This evidence concerns the gene ALK and non-small cell lung carcinoma.